Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 34052 | 79 | 20.1 | 69% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 81 | 26583 | MYELODYSPLASTIC SYNDROMES//ACUTE MYELOID LEUKEMIA//LEUKEMIA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CHROMOSOME 5 ABNORMALITY | Author keyword | 1 | 50% | 1% | 1 |
| 2 | PHARM NTHC NARILIS | Address | 1 | 50% | 1% | 1 |
| 3 | UNIDAD HEMATOL CLIN | Address | 1 | 50% | 1% | 1 |
| 4 | CHROMOSOMES HUMAN PAIR 20 | Author keyword | 0 | 33% | 1% | 1 |
| 5 | GASTROENTEROLDIGEST SURG | Address | 0 | 33% | 1% | 1 |
| 6 | HOSP CASA MATERNITAT | Address | 0 | 20% | 1% | 1 |
| 7 | PHARMACOVIGILANCE RISK MANAGEMENT SECT | Address | 0 | 20% | 1% | 1 |
| 8 | HAEMATOL ONCOL BONE MARROW TRANSPLANTAT | Address | 0 | 13% | 1% | 1 |
| 9 | INTERLEUKIN 2R | Author keyword | 0 | 13% | 1% | 1 |
| 10 | UO CHIRURG GEN TR IANTI FEGATO | Address | 0 | 13% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CHROMOSOME 5 ABNORMALITY | 1 | 50% | 1% | 1 | Search CHROMOSOME+5+ABNORMALITY | Search CHROMOSOME+5+ABNORMALITY |
| 2 | CHROMOSOMES HUMAN PAIR 20 | 0 | 33% | 1% | 1 | Search CHROMOSOMES++HUMAN++PAIR+20 | Search CHROMOSOMES++HUMAN++PAIR+20 |
| 3 | INTERLEUKIN 2R | 0 | 13% | 1% | 1 | Search INTERLEUKIN+2R | Search INTERLEUKIN+2R |
| 4 | LOWER INTESTINAL LESION | 0 | 100% | 1% | 1 | Search LOWER+INTESTINAL+LESION | Search LOWER+INTESTINAL+LESION |
Key Words Plus |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Acute myeloid leukemia following solid organ transplantation: entity or novelty? | 2014 | 1 | 17 | 53% |
| Azathioprine: Association with Therapy-related Myelodysplastic Syndrome and Acute Myeloid Leukemia | 2010 | 9 | 27 | 52% |
| Hematological malignancies in chronic inflammatory bowel diseases: report of five cases and review of the literature | 2007 | 8 | 32 | 41% |
| Azathioprine-associated acute myeloid leukaemia with trilineage dysplasia and complex karyotype: a case report and review of the literature | 1999 | 17 | 10 | 50% |
| Thyroid Cancer and T Lymphoblastic Leukemia in Crohn Disease: A Case Report and Literature Review | 2015 | 0 | 21 | 48% |
| ACUTE PROMYELOCYTIC LEUKEMIA IN CROHNS-DISEASE - CASE-REPORT AND REVIEW OF THE LITERATURE | 1991 | 11 | 6 | 67% |
| Concurrent development of Crohn disease and myelodysplastic syndrome in a child: Case report and literature review | 2006 | 0 | 13 | 62% |
| Commentary: does immune suppression increase risk of developing acute myeloid leukemia? | 2012 | 9 | 9 | 11% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PHARM NTHC NARILIS | 1 | 50% | 1.3% | 1 |
| 2 | UNIDAD HEMATOL CLIN | 1 | 50% | 1.3% | 1 |
| 3 | GASTROENTEROLDIGEST SURG | 0 | 33% | 1.3% | 1 |
| 4 | HOSP CASA MATERNITAT | 0 | 20% | 1.3% | 1 |
| 5 | PHARMACOVIGILANCE RISK MANAGEMENT SECT | 0 | 20% | 1.3% | 1 |
| 6 | HAEMATOL ONCOL BONE MARROW TRANSPLANTAT | 0 | 13% | 1.3% | 1 |
| 7 | UO CHIRURG GEN TR IANTI FEGATO | 0 | 13% | 1.3% | 1 |
| 8 | ABT TRANSPLANTAT IMMUNOL | 0 | 11% | 1.3% | 1 |
| 9 | CORPORACIO SANITARIA CLIN | 0 | 11% | 1.3% | 1 |
| 10 | HEMOPATHOL UNIT | 0 | 11% | 1.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000192196 | SECONDARY LEUKEMIA//SECOND MALIGNANT NEOPLASM//THERAPY RELATED |
| 2 | 0.0000189030 | DE NOVO MALIGNANCIES//DONOR MALIGNANCY//TUMOR TRANSMISSION |
| 3 | 0.0000178935 | IMMUNODEFICIENCY ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS//RADIATION THERAPY COMPLICATIONS//STANDARDIZED INCIDENCE RATE |
| 4 | 0.0000156620 | SURVEILLANCE COLONOSCOPY//DALM//DYSPLASIA ASSOCIATED LESION OR MASS |
| 5 | 0.0000154173 | JUMPING TRANSLOCATION//INTERSTITIAL TELOMERIC SEQUENCES//TELOMERE ASSOCIATION |
| 6 | 0.0000132368 | PARANEOPLASTIC VASCULITIS//PALMAR FASCIITIS//LEUKEMIC ARTHRITIS |
| 7 | 0.0000120353 | THIOPURINE METHYLTRANSFERASE//6 MERCAPTOPURINE//THIOPURINE S METHYLTRANSFERASE |
| 8 | 0.0000106255 | DEK//ACUTE BASOPHILIC LEUKEMIA//DEK CAN |
| 9 | 0.0000099612 | POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER//PTLD//POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE |
| 10 | 0.0000085437 | TETRASOMY 8//NEAR TETRAPLOIDY//TRISOMY 4 |